{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:38:01Z","timestamp":1781059081958,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The ongoing COVID-19 pandemic has created an urgency to identify novel vaccine targets for protective immunity against SARS-CoV-2. Early reports identify protective roles for both humoral and cell-mediated immunity for SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We leveraged our bioinformatics binding prediction tools for human leukocyte antigen (HLA)-I and HLA-II alleles that were developed using mass spectrometry-based profiling of individual HLA-I and HLA-II alleles to predict peptide binding to diverse allele sets. We applied these binding predictors to viral genomes from the\n                      <jats:italic>Coronaviridae<\/jats:italic>\n                      family and specifically focused on T cell epitopes from SARS-CoV-2 proteins. We assayed a subset of these epitopes in a T cell induction assay for their ability to elicit CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We first validated HLA-I and HLA-II predictions on\n                      <jats:italic>Coronaviridae<\/jats:italic>\n                      family epitopes deposited in the Virus Pathogen Database and Analysis Resource (ViPR) database. We then utilized our HLA-I and HLA-II predictors to identify 11,897 HLA-I and 8046 HLA-II candidate peptides which were highly ranked for binding across 13 open reading frames (ORFs) of SARS-CoV-2. These peptides are predicted to provide over 99% allele coverage for the US, European, and Asian populations. From our SARS-CoV-2-predicted peptide-HLA-I allele pairs, 374 pairs identically matched what was previously reported in the ViPR database, originating from other coronaviruses with identical sequences. Of these pairs, 333 (89%) had a positive HLA binding assay result, reinforcing the validity of our predictions. We then demonstrated that a subset of these highly predicted epitopes were immunogenic based on their recognition by specific CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells in healthy human donor peripheral blood mononuclear cells (PBMCs). Finally, we characterized the expression of SARS-CoV-2 proteins in virally infected cells to prioritize those\u00a0which could be potential targets for T cell immunity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Using our bioinformatics platform, we identify multiple putative epitopes that are potential targets for CD4\n                      <jats:sup>+<\/jats:sup>\n                      and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, whose HLA binding properties cover nearly the entire population. We also confirm that our binding predictors can predict epitopes eliciting CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell responses from multiple SARS-CoV-2 proteins. Protein expression and population HLA allele coverage, combined with the ability to identify T cell epitopes, should be considered in SARS-CoV-2 vaccine design strategies and immune monitoring.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-020-00767-w","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T13:10:30Z","timestamp":1597324230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-1051","authenticated-orcid":false,"given":"Asaf","family":"Poran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi","family":"Harjanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Malloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Arieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Lenkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit M.","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri A.","family":"Addona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Gaynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"issue":"3","key":"767_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181\u201392.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"767_CR2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","volume":"202","author":"J Gu","year":"2005","unstructured":"Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415\u201324.","journal-title":"J Exp Med"},{"issue":"5624","key":"767_CR3","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","volume":"300","author":"PA Rota","year":"2003","unstructured":"Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300(5624):1394\u20139.","journal-title":"Science."},{"issue":"20","key":"767_CR4","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953\u201366.","journal-title":"N Engl J Med"},{"key":"767_CR5","unstructured":"WHO MERS-CoV Global summary and assessment of risk. World Health Organization; 2018. Available from: https:\/\/www.who.int\/csr\/disease\/coronavirus_infections\/risk-assessment-august-2018.pdf."},{"key":"767_CR6","unstructured":"WHO | Middle East respiratory syndrome coronavirus (MERS-CoV). WHO. World Health Organization; [cited 2020 Mar 25]. Available from: http:\/\/www.who.int\/emergencies\/mers-cov\/en\/."},{"key":"767_CR7","unstructured":"WHO | Update 49 - SARS case fatality ratio, incubation period. WHO. World Health Organization; [cited 2020 Mar 25]. Available from: https:\/\/www.who.int\/csr\/sars\/archive\/2003_05_07a\/en\/."},{"key":"767_CR8","unstructured":"Coronavirus disease (COVID-19) Pandemic. [cited 2020 Mar 25]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"issue":"1","key":"767_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF-W Chan","year":"2020","unstructured":"Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221\u201336.","journal-title":"Emerg Microbes Infect"},{"issue":"7798","key":"767_CR10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133.","journal-title":"Nature."},{"issue":"10224","key":"767_CR11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565. 74.","journal-title":"Lancet"},{"key":"767_CR12","doi-asserted-by":"crossref","unstructured":"Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020 25;12(3).","DOI":"10.3390\/v12030254"},{"issue":"5","key":"767_CR13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41423-020-0385-z","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng M, Song L. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. Cellular & Molecular Immunology. 2020;17(5):536\u20138.","journal-title":"Cellular & Molecular Immunology"},{"issue":"6483","key":"767_CR14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260\u20133.","journal-title":"Science."},{"issue":"2","key":"767_CR15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281\u201392. e6.","journal-title":"Cell"},{"issue":"4","key":"767_CR16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424\u201332.","journal-title":"J Med Virol"},{"issue":"6982","key":"767_CR17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","volume":"428","author":"Z-Y Yang","year":"2004","unstructured":"Yang Z-Y, Kong W-P, Huang Y, Roberts A, Murphy BR, Subbarao K, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 2004;428(6982):561\u20134.","journal-title":"Nature."},{"issue":"12","key":"767_CR18","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/nm.2972","volume":"18","author":"RL Graham","year":"2012","unstructured":"Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, Baric RS. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat Med. 2012;18(12):1820\u20136.","journal-title":"Nat Med"},{"issue":"12","key":"767_CR19","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1373\/clinchem.2003.023184","volume":"49","author":"J Wang","year":"2003","unstructured":"Wang J, Wen J, Li J, Yin J, Zhu Q, Wang H, et al. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin Chem. 2003;49(12):1989\u201396.","journal-title":"Clin Chem"},{"issue":"1","key":"767_CR20","first-page":"227","volume":"11","author":"X Liu","year":"2004","unstructured":"Liu X, Shi Y, Li P, Li L, Yi Y, Ma Q, et al. Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clin Diagn Lab Immunol. 2004;11(1):227\u20138.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"767_CR21","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","volume":"186","author":"F Tang","year":"2011","unstructured":"Tang F, Quan Y, Xin Z-T, Wrammert J, Ma M-J, Lv H, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011;186(12):7264\u20138.","journal-title":"J Immunol"},{"issue":"1","key":"767_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20499","volume":"78","author":"L Zhang","year":"2006","unstructured":"Zhang L, Zhang F, Yu W, He T, Yu J, Yi CE, et al. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006;78(1):1\u20138.","journal-title":"J Med Virol"},{"key":"767_CR23","doi-asserted-by":"publisher","unstructured":"Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 [published online ahead of print, 2020 Mar 28]. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa344.","DOI":"10.1093\/cid\/ciaa344"},{"key":"767_CR24","doi-asserted-by":"crossref","unstructured":"Okba NMA, M\u00fcller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, et al. Early release - severe acute respiratory syndrome coronavirus 2\u2212specific antibody responses in coronavirus disease 2019 patients - Volume 26, Number 7\u2014July 2020 - Emerging Infectious Diseases journal - CDC. [cited 2020 May 11]; Available from: https:\/\/wwwnc.cdc.gov\/eid\/article\/26\/7\/20-0841_article.","DOI":"10.3201\/eid2607.200841"},{"issue":"5","key":"767_CR25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269\u201370.","journal-title":"Nat Rev Immunol"},{"key":"767_CR26","doi-asserted-by":"crossref","unstructured":"Channappanavar R, Zhao J, Perlman S. T-cell-mediated immune response to respiratory coronaviruses. Immunol Res 2014;59(0):118\u2013128.","DOI":"10.1007\/s12026-014-8534-z"},{"issue":"8","key":"767_CR27","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","volume":"181","author":"CK Li","year":"2008","unstructured":"Li CK, Wu H, Yan H, Ma S, Wang L, Zhang M, et al. T cell responses to whole SARS coronavirus in humans. J Immunol. 2008;181(8):5490\u2013500.","journal-title":"J Immunol"},{"key":"767_CR28","first-page":"1","volume":"16","author":"I Thevarajan","year":"2020","unstructured":"Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020;16:1\u20133.","journal-title":"Nat Med"},{"key":"767_CR29","doi-asserted-by":"crossref","unstructured":"Ni L, Ye F, Cheng M-L, Feng Y, Deng Y-Q, Zhao H, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;S1074761320301813.","DOI":"10.1016\/j.immuni.2020.04.023"},{"key":"767_CR30","doi-asserted-by":"crossref","unstructured":"Weiskopf D, Schmitz KS, Raadsen MP, Grifoni A, Okba NMA, Endeman H, et al. Phenotype and kinetics of SARS-CoV-2\u2013specific T cells in COVID-19 patients with acute respiratory distress syndrome. Science Immunology. 2020 [cited 2020 Jul 17];5(48). Available from: https:\/\/immunology.sciencemag.org\/content\/5\/48\/eabd2071.","DOI":"10.1126\/sciimmunol.abd2071"},{"issue":"17","key":"767_CR31","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","volume":"34","author":"O-W Ng","year":"2016","unstructured":"Ng O-W, Chia A, Tan AT, Jadi RS, Leong HN, Bertoletti A, et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016;34(17):2008\u201314.","journal-title":"Vaccine."},{"key":"767_CR32","doi-asserted-by":"crossref","unstructured":"Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;S0092867420306103.","DOI":"10.1016\/j.cell.2020.05.015"},{"key":"767_CR33","doi-asserted-by":"crossref","unstructured":"Abelin JG, Keskin DB, Sarkizova S, Hartigan CR, Zhang W, Sidney J, et al. Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction. Immunity. 2017;46(2):315\u201326.","DOI":"10.1016\/j.immuni.2017.02.007"},{"key":"767_CR34","doi-asserted-by":"crossref","unstructured":"Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, et al. Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction. Immunity. 2019;51(4):766\u2013779.e17.","DOI":"10.1016\/j.immuni.2019.08.012"},{"key":"767_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4939-6925-8_16","volume":"1592","author":"LLD Archila","year":"2017","unstructured":"Archila LLD, Kwok WW. Tetramer-guided epitope mapping: a rapid approach to identify HLA-restricted T-cell epitopes from composite allergens. Methods Mol Biol. 2017;1592:199\u2013209.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"767_CR36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2006.03.008","volume":"120","author":"J Yang","year":"2006","unstructured":"Yang J, James EA, Huston L, Danke NA, Liu AW, Kwok WW. Multiplex mapping of CD4 T cell epitopes using class II tetramers. Clin Immunol. 2006;120(1):21\u201332.","journal-title":"Clin Immunol"},{"key":"767_CR37","doi-asserted-by":"crossref","unstructured":"Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 2019 08;47(D1):D339\u201343.","DOI":"10.1093\/nar\/gky1006"},{"key":"767_CR38","doi-asserted-by":"crossref","unstructured":"Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A. A sequence homology and Bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell Host Microbe. 2020;12.","DOI":"10.1016\/j.chom.2020.03.002"},{"issue":"Database issue","key":"767_CR39","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gkr859","volume":"40","author":"BE Pickett","year":"2012","unstructured":"Pickett BE, Sadat EL, Zhang Y, Noronha JM, Squires RB, Hunt V, et al. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 2012;40(Database issue):D593\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"7816","key":"767_CR40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","volume":"583","author":"D Bojkova","year":"2020","unstructured":"Bojkova D, Klann K, Koch B, Widera M, Krause D, Ciesek S, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583(7816):469\u201372.","journal-title":"Nature."},{"key":"767_CR41","unstructured":"Bezstarosti K, Lamers MM, Haagmans BL, Demmers JAA. Targeted proteomics for the detection of SARS-CoV-2 proteins. bioRxiv. 2020;2020.04.23.057810."},{"key":"767_CR42","doi-asserted-by":"publisher","unstructured":"Davidson, A.D., Williamson, M.K., Lewis, S.\u00a0et al.\u00a0Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.\u00a0Genome Med\u00a012,\u00a068 (2020). https:\/\/doi.org\/10.1186\/s13073-020-00763-0.","DOI":"10.1186\/s13073-020-00763-0"},{"issue":"9","key":"767_CR43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.humimm.2007.04.005","volume":"68","author":"M Maiers","year":"2007","unstructured":"Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol. 2007;68(9):779\u201388.","journal-title":"Hum Immunol"},{"key":"767_CR44","unstructured":"U.S. Census Bureau QuickFacts: United States. [cited 2020 Jun 24]. Available from: https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045219."},{"issue":"Database issue","key":"767_CR45","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","volume":"43","author":"FF Gonz\u00e1lez-Galarza","year":"2015","unstructured":"Gonz\u00e1lez-Galarza FF, Takeshita LYC, Santos EJM, Kempson F, Maia MHT, da Silva ALS, et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 2015;43(Database issue):D784\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"767_CR46","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996\u20131006.","journal-title":"Genome Res"},{"issue":"7","key":"767_CR47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nmeth.1345","volume":"6","author":"SR Hadrup","year":"2009","unstructured":"Hadrup SR, Bakker AH, Shu CJ, Andersen RS, van Veluw J, Hombrink P, et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods. 2009;6(7):520\u20136.","journal-title":"Nat Methods"},{"issue":"2","key":"767_CR48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nm1360","volume":"12","author":"M Toebes","year":"2006","unstructured":"Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ, et al. Design and use of conditional MHC class I ligands. Nat Med. 2006;12(2):246\u201351.","journal-title":"Nat Med"},{"issue":"6","key":"767_CR49","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","volume":"44","author":"J Zhao","year":"2016","unstructured":"Zhao J, Zhao J, Mangalam AK, Channappanavar R, Fett C, Meyerholz DK, et al. Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity. 2016;44(6):1379\u201391.","journal-title":"Immunity."},{"issue":"6","key":"767_CR50","doi-asserted-by":"crossref","first-page":"a006957","DOI":"10.1101\/cshperspect.a006957","volume":"4","author":"Y Xing","year":"2012","unstructured":"Xing Y, Hogquist KA. T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol. 2012;4(6):a006957.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"767_CR51","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-18-1494","volume":"9","author":"MR Parkhurst","year":"2019","unstructured":"Parkhurst MR, Robbins PF, Tran E, Prickett TD, Gartner JJ, Jia L, et al. Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers. Cancer Discov. 2019;9(8):1022\u201335.","journal-title":"Cancer Discov"},{"issue":"7528","key":"767_CR52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","volume":"515","author":"M Yadav","year":"2014","unstructured":"Yadav M, Jhunjhunwala S, Phung QT, Lupardus P, Tanguay J, Bumbaca S, et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature. 2014;515(7528):572\u20136.","journal-title":"Nature."},{"issue":"6291","key":"767_CR53","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.aaf2288","volume":"352","author":"E Stronen","year":"2016","unstructured":"Stronen E, Toebes M, Kelderman S, van Buuren MM, Yang W, van Rooij N, et al. Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. Science. 2016;352(6291):1337\u201341.","journal-title":"Science."},{"issue":"6","key":"767_CR54","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/s41596-019-0170-6","volume":"14","author":"M Ali","year":"2019","unstructured":"Ali M, Foldvari Z, Giannakopoulou E, B\u00f6schen M-L, Str\u00f8nen E, Yang W, et al. Induction of neoantigen-reactive T cells from healthy donors. Nat Protoc. 2019;14(6):1926\u201343.","journal-title":"Nat Protoc"},{"issue":"14","key":"767_CR55","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1021\/ac0498563","volume":"76","author":"H Liu","year":"2004","unstructured":"Liu H, Sadygov RG, Yates JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem. 2004;76(14):4193\u2013201.","journal-title":"Anal Chem"},{"issue":"9","key":"767_CR56","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/pr060161n","volume":"5","author":"B Zybailov","year":"2006","unstructured":"Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res. 2006;5(9):2339\u201347.","journal-title":"J Proteome Res"},{"key":"767_CR57","doi-asserted-by":"publisher","unstructured":"Ihling C, T\u00e4nzler D, Hagemann S, Kehlen A, H\u00fcttelmaier S, Arlt C, et al. Mass spectrometric identification of SARS-CoV-2 proteins from gargle solution samples of COVID-19 patients. J Proteome Res. 2020 [cited 2020 Jul 17]; Available from: https:\/\/doi.org\/10.1021\/acs.jproteome.0c00280.","DOI":"10.1021\/acs.jproteome.0c00280"},{"issue":"12","key":"767_CR58","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1128\/JCM.41.12.5781-5782.2003","volume":"41","author":"Y Shi","year":"2003","unstructured":"Shi Y, Yi Y, Li P, Kuang T, Li L, Dong M, et al. Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus Nucleocapsid antibodies in an antigen-capturing enzyme-linked Immunosorbent assay. J Clin Microbiol. 2003;41(12):5781\u20132.","journal-title":"J Clin Microbiol"},{"key":"767_CR59","doi-asserted-by":"crossref","unstructured":"Kim D, Lee J-Y, Yang J-S, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell. 2020 [cited 2020 May 9]; Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0092867420304062.","DOI":"10.1016\/j.cell.2020.04.011"},{"key":"767_CR60","doi-asserted-by":"crossref","unstructured":"Shomuradova AS, Vagida MS, Sheetikov SA, Zornikova KV, Kiryukhin D, Titov A, et al. SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors. 2020 May [cited 2020 Jun 24]. Available from: http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2020.05.20.20107813.","DOI":"10.2139\/ssrn.3640836"},{"key":"767_CR61","doi-asserted-by":"crossref","unstructured":"Chour W, Xu AM, Ng AHC, Choi J, Xie J, Yuan D, et al. Shared antigen-specific CD8+ T cell responses against the SARS-COV-2 spike protein in HLA A*02:01 COVID-19 participants. 2020 May [cited 2020 Jun 24]. Available from: http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2020.05.04.20085779.","DOI":"10.1101\/2020.05.04.20085779"},{"key":"767_CR62","doi-asserted-by":"crossref","unstructured":"J\u00fanior IJM, Polveiro RC, Souza GM, Bortolin DI, Sassaki FT, Lima ATM. The global population of SARS-CoV-2 is composed of six major subtypes. bioRxiv. 2020;2020.04.14.040782.","DOI":"10.1101\/2020.04.14.040782"},{"key":"767_CR63","first-page":"1","volume":"17","author":"SF Ahmed","year":"2020","unstructured":"Ahmed SF, Quadeer AA, McKay MR. COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2. Nat Protoc. 2020;17:1\u20132.","journal-title":"Nat Protoc"},{"key":"767_CR64","doi-asserted-by":"crossref","unstructured":"Singer J, Gifford R, Cotten M, Robertson D. CoV-GLUE: a web application for tracking SARS-CoV-2 genomic variation. Life Sciences; 2020 Jun [cited 2020 Jun 24]. Available from: https:\/\/www.preprints.org\/manuscript\/202006.0225\/v1.","DOI":"10.20944\/preprints202006.0225.v1"},{"issue":"2","key":"767_CR65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","volume":"38","author":"S Sarkizova","year":"2020","unstructured":"Sarkizova S, Klaeger S, Le PM, Li LW, Oliveira G, Keshishian H, et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat Biotechnol. 2020;38(2):199\u2013209.","journal-title":"Nat Biotechnol"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-020-00767-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-020-00767-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-020-00767-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T16:31:05Z","timestamp":1667752265000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-020-00767-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1186\/s13073-020-00767-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.06.027805","asserted-by":"object"}]},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AP, DH, MM, CMA, DAR, DL, MMvB, TAA, MSR, LS, and RBG are all current or past\u00a0employees and shareholders of BioNTech US (formerly Neon Therapeutics, Inc.).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}